Selecting and characterizing drug-resistant hepatitis C virus replicon.

Inge Vliegen1, Leen Delang, Johan Neyts

  • 1Rega Institute for Medical Research, Leuven, Belgium.

Summary

Researchers developed four methods to create drug-resistant hepatitis C virus (HCV) in vitro. This research is crucial for understanding how resistance emerges against new HCV replication inhibitors.